Peter Campbell

Peter is a senior group leader at the Wellcome Sanger Institute where his research programme focuses on the genetic changes cells acquire throughout life, and how these mutations are related to ageing, cancer and other disease processes.

His current research focuses on cancer genomics, and in particular genome-wide analyses of somatic mutations in tumours. Outside of cancer, his focus areas include how somatic mutations delineate clonal relationships of normal cellular populations and how somatic mutations affect normal cellular behaviour.

Peter received his PhD from the University of Cambridge and completed his postdoctoral fellowship at the Wellcome Sanger Institute.